Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia

被引:37
作者
Aimoto, Mizuki [1 ]
Koh, Hideo [1 ]
Katayama, Takako [1 ]
Okamura, Hiroshi [1 ]
Yoshimura, Takuro [1 ]
Koh, Shiro [1 ]
Nanno, Satoru [1 ]
Nishimoto, Mitsutaka [1 ]
Hirose, Asao [1 ]
Nakamae, Mika [1 ]
Nakane, Takahiko [1 ]
Nakamae, Hirohisa [1 ]
Kakeya, Hiroshi [2 ]
Hino, Masayuki [1 ]
机构
[1] Osaka City Univ, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan
[2] Osaka City Univ, Grad Sch Med, Dept Infect Control Sci, Abeno Ku, Osaka 5458585, Japan
基金
日本学术振兴会;
关键词
High-sensitivity procalcitonin; C-reactive protein; Febrile neutropenia; Septic shock; Non-CNS bacteremia; EXPRESSION; SEPSIS; MARKER; GENE;
D O I
10.1007/s15010-014-0657-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Although a few prospective studies have addressed the question as to which biomarker of infection in adult patients with febrile neutropenia (FN) is superior, procalcitonin (PCT) or C-reactive protein (CRP), the results have been inconsistent and inconclusive. This was possibly due to the poor sensitivity of previous PCT tests that have a functional sensitivity of 0.5 ng/ml. Between November 2010 and February 2012, we prospectively compared the diagnostic utility of serum high-sensitivity (hs) PCT (lower limit of detection, 0.02 ng/ml) and CRP levels for detecting bacterial infection in patients with FN. Serum was collected within 72 h after the onset of FN in patients with hematological disorders. Seventy-five febrile episodes were evaluable. The areas under the receiver operating characteristic curves for life-threatening infection defined as septic shock and bacteremia caused by non-coagulase negative staphylococcus were 0.824 (95 % CI 0.711-0.937; P = 0.001) for hsPCT and 0.673 (0.505-0.842; P = 0.068) for CRP, respectively. In contrast, CRP, but not hsPCT, tended to increase significantly with the clinical severity, as indicated by the diagnostic classification (P = 0.002 for trend). The serum hsPCT test may be more useful than the serum CRP test in the detection of life-threatening infection at an early phase after the onset of FN. In contrast, the serum CRP test may be more useful in diagnosing the severity of infection. However, neither of these tests was able to differentiate the cause of FN with a low probability of fatal outcome.
引用
收藏
页码:971 / 979
页数:9
相关论文
共 20 条
  • [1] [Anonymous], 1990, J Infect Dis, V161, P397
  • [2] Pyocalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
    Becker, Kenneth L.
    Snider, Richard
    Nylen, Eric S.
    [J]. CRITICAL CARE MEDICINE, 2008, 36 (03) : 941 - 952
  • [3] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [4] Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
    Freifeld, Alison G.
    Bow, Eric J.
    Sepkowitz, Kent A.
    Boeckh, Michael J.
    Ito, James I.
    Mullen, Craig A.
    Raad, Issam I.
    Rolston, Kenneth V.
    Young, Jo-Anne H.
    Wingard, John R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (04) : E56 - E93
  • [5] Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia:: experience from a multicentre study
    Giamarellou, H
    Giamarellos-Bourboulis, EJ
    Repoussis, P
    Galani, L
    Anagnostopoulos, N
    Grecka, P
    Lubos, D
    Aoun, M
    Athanassiou, K
    Bouza, E
    Devigili, E
    Krçmery, V
    Menichetti, F
    Panaretou, E
    Papageorgiou, E
    Plachouras, D
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (07) : 628 - 633
  • [6] Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia
    Jimeno, A
    Garcia-Velasco, A
    del Val, O
    González-Billalabeitia, E
    Hernando, S
    Hernández, R
    Sánchez-Muñoz, A
    López-Martín, A
    Durán, I
    Robles, L
    Cortés-Funes, H
    Paz-Ares, L
    [J]. CANCER, 2004, 100 (11) : 2462 - 2469
  • [7] Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis
    Kagebayashi, Chiaki
    Yamaguchi, Isao
    Akinaga, Ayumi
    Kitano, Hiromichi
    Yokoyama, Kazunori
    Satomura, Masahiro
    Kurosawa, Tatsuo
    Watanabe, Mitsuo
    Kawabata, Tomohisa
    Chang, William
    Li, Chen
    Bousse, Luc
    Wada, Henry G.
    Satomura, Shinji
    [J]. ANALYTICAL BIOCHEMISTRY, 2009, 388 (02) : 306 - 311
  • [8] Investigation of the freely available easy-to-use software 'EZR' for medical statistics
    Kanda, Y.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 (03) : 452 - 458
  • [9] Bacteraernia in febrile neutropenic cancer patients
    Klastersky, J.
    Ameye, L.
    Maertens, J.
    Georgala, A.
    Muanza, F.
    Aoun, M.
    Ferrant, A.
    Rapoport, B.
    Rolston, K.
    Paesmans, M.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 : S51 - S59
  • [10] Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever
    Lin, Chou-Han
    Yao, Ming
    Hsu, Szu-Chun
    Ho, Chao-Chi
    Lin, Ming-Tzer
    Lin, Chih-An
    Hu, Fu-Chang
    Yu, Chong-Jen
    Tien, Hwei-Fang
    [J]. CRITICAL CARE MEDICINE, 2011, 39 (05) : 993 - 999